Amphastar Pharmaceuticals, Inc.

NASDAQ:AMPH

Drug Manufacturers - Specialty & Generic

Healthcare
$29.71 -1.60%

-$0.31 today

Market cap
$1.27B
Beta
0.90
P/E (TTM)
10.9
EPS (TTM)
$1.75
52W Low $16.65High $31.26

Volume 0.53M

Average 0.59M

AMPH Net Receivables

Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.

Amphastar Pharmaceuticals, Inc.NASDAQ: AMPH

Net Receivables · Q1 FY2026 · quarter ended Mar 2026

Net receivables broadly unchanged from a year ago

Net receivables stood at $147.85M at the end of Q1 FY2026, up 1.7% from a year earlier and up 3.0% from the prior quarter. Over 3 fiscal years it compounded at +17.4% a year.

Context

  • Net receivables amounted to 9.0% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
  • Net receivables increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether net receivables keeps rising in the next quarterly balance sheet after a +1.7% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$147.85M+3.0% QoQ
Last fiscal yearDec 2025
$143.56M+4.0% YoY
Year agoMar 2025
$145.39M+1.7% since
Net Receivables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+1.7%——
1 year+4.0%——
3-year CAGR+17.4%——
5-year CAGR——
10-year CAGR——

Net Receivables history

USD · from the balance sheet

Latest · FY2025
143.56M USD
Year-over-year change
+4.0%
4-year CAGR
+16.2%

Net Receivables vs competitors

How AMPH compares with its peers on the latest reported figures

  • Peers report in different currencies, so net receivables is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of +1.7% is the 4th highest of 8, against a peer median of +0.0%.
  • Net receivables amounts to 9.0% of total assets for AMPH, versus a peer median of 13.7%.
AMPH Competitors
Net Receivables for AMPH and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
RDYDr. Reddy's Laboratories LimitedSep 2026₹101.84B INR-15.7%+6.0%17.7%
VTRSViatris Inc.Jun 2026$3.67B USD+2.0%-6.9%10.5%
TEVATeva Pharmaceutical Industries LimitedJun 2026$3.49B USD-2.0%+0.1%8.8%
BHCBausch Health Companies Inc.Jun 2026$2.26B USD+2.4%+9.4%9.1%
AMRXAmneal Pharmaceuticals, Inc.Jun 2026$1.02B USD+20.2%+8.2%27.0%
COLLCollegium Pharmaceutical, Inc.Mar 2026$228.76M USD+0.0%+4.9%13.8%
AMPHAmphastar Pharmaceuticals, Inc.Mar 2026$147.85M USD+1.7%+17.4%9.0%
ETONEton Pharmaceuticals, Inc.Mar 2026$13.41M USD-18.2%+85.2%13.7%
Peer median (excluding AMPH) —+0.0%+6.0%13.7%

Competitors are the stored peer set for AMPH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents126.35M156.1M144.3M151.61M170.18M
Short-term Investments10.32M19.66M112.51M70.04M112.64M
Net Receivables78.8M88.8M115.47M138.04M143.56M
Inventory92.81M103.58M105.83M153.74M176.89M
Other Current Assets2.56M2.61M11.49M20.65M32.75M
Total Current Assets318.12M378.32M489.6M534.07M636.02M
Property, Plant & Equipment (Net)271.49M264.57M315.64M344.63M353.72M
Goodwill3.31M3.13M3.22M3.05M3.4M
Intangible Assets35.56M34.17M610.08M587.61M562.56M
Long-term Investments3.99M2.41M15.21M11M0
Tax Assets22.4M38.53M53.25M71.12M42.46M
Other Non-current Assets16.67M20.86M25.91M25.99M31.14M
Total Non-current Assets353.41M363.67M1.02B1.04B993.28M
Total Assets671.53M741.99M1.51B1.58B1.63B
Account Payables22.21M20.5M25.44M30.51M32.59M
Short-term Debt2.2M3.05M436K234K1.64M
Tax Payables9.08M4.57M1.61M9.66M17.17M
Deferred Revenue00000
Other Current Liabilities23.16M17.55M000
Total Current Liabilities103.81M94.86M225.41M173.76M158.16M
Long-term Debt74.38M72.84M589.58M601.63M608.66M
Deferred Tax Liabilities7.07M7.37M6.07M6.96M5.93M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities15.65M14.57M22.72M20.95M29.98M
Total Non-current Liabilities122.2M118.47M648.08M671.41M682.34M
Total Liabilities226.01M213.33M873.49M845.17M840.49M
Common Stock6K6K6K6K6K
Retained Earnings180.34M271.72M409.27M568.79M666.88M
Accumulated OCI(6.77M)(8.62M)(8.48M)(9.18M)(5.31M)
Other Stockholders Equity00000
Minority Interest00000
Total Equity445.52M528.66M639.42M732.3M788.81M
Total Debt104.66M102.58M623.64M650.55M656M
Net Debt(21.69M)(53.52M)479.35M498.94M485.83M

Amphastar Pharmaceuticals, Inc.

NASDAQ:AMPH

Intrinsic Alpha fair value

Locked

Current Price

$29.71

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.